REFERENCE
Walensky RP, Weinstein MC, Yazdanpanah Y, Losina E, Mercincavage LM, Touré S, Divi N, Anglaret X, Goldie SJ, Freedberg KA, CEPAC International Investigators.HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS 21: 973-982, No. 8, 11 May 2007
Rights and permissions
About this article
Cite this article
Drug resistance surveillance of little value for ART sequencing. Pharmacoecon. Outcomes News 532, 6 (2007). https://doi.org/10.2165/00151234-200705320-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705320-00009